Table 4.
Interaction between genetic variants and pathogen exposure on plasma CRP in 1,709 CLHNS individuals
SNP | Gene | Low pathogen exposure | High pathogen exposure | P (inter) | ||
---|---|---|---|---|---|---|
β (SE) | P | β (SE) | P | |||
rs876537 | CRP | 0.220 (0.067) | 0.0010 | 0.345 (0.067) | 3.6E-07 | 0.18 |
rs7305618 | HNF1A | 0.181 (0.066) | 0.0063 | 0.348 (0.065) | 1.3E-07 | 0.031 |
rs429358 | APOE | 0.333 (0.108) | 0.0022 | 0.256 (0.112) | 0.022 | 0.85 |
rs1892534 | LEPR | 0.249 (0.088) | 0.0047 | 0.068 (0.089) | 0.44 | 0.030 |
rs4129267 | IL6R | 0.010 (0.081) | 0.90 | 0.144 (0.082) | 0.079 | 0.097 |
rs1260326 | GCKR | 0.066 (0.066) | 0.32 | 0.053 (0.069) | 0.45 | 0.69 |
rs10778213 | 12q23.2 | 0.062 (0.077) | 0.42 | 0.010 (0.077) | 0.90 | 0.72 |
rs1408282 | 6q16.1 | 0.226 (0.119) | 0.057 | 0.593 (0.123) | 1.5E-06 | 0.046 |
Pathogen score < 0.5 (median) was defined as low pathogen exposure (n = 877, 51.3%) while the pathogen score ≥ 0.5 was defined as high pathogen exposure (n = 832, 48.7%); P (inter): P for interaction between genotype and pathogen score on CRP level.